Pfizer and Flynn Pharma fined £69 million for charging excessive prices on epilepsy drugs
Pfizer and Flynn Pharma, manufacturers of phenytoin sodium capsules which are used to treat epilepsy, have been fined a combined total of £69 million by the Competitions Appeal Tribunal (CAT) for “charging excessive prices” between 2012 and 2016. Around 48,000 …